Clinical trial
ACE Inhibition and Novel Cardiovascular Risk Factors
NCT00051389 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACE Inhibition and Novel Cardiovascular Risk Factors
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- January 31, 2007
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.